Stocks Health care ICCM
NASDAQ · Health careIceCure Medical Ltd. (ICCM)
IceCure Medical Ltd. reported revenue of $3.4M in fiscal 2025, up 2.7% from a year earlier. It posted a net loss of $15.1M. In fiscal 2025 capital spending exceeded operating cash flow by $14.6M. At December 31, 2025 it held $8.9M in cash against $13K of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 17, 2026.
Key facts about IceCure Medical Ltd.
- Net worth
- IceCure Medical Ltd. has a market value (market cap) of $2.5M at the latest share price, and shareholders' equity of $9.1M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $3.4M (+2.7% year on year), with a net loss of $15.1M.
- Cash flow
- In fiscal 2025 operations used $14.6M of cash.
- Latest report
- The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on March 17, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
What IceCure Medical Ltd. does
IceCure Medical Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker ICCM.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $3.4M | -$15.1M | $0.24 | -$14.6M |
| 2024 | $3.3M | -$15.3M | $0.30 | -$12.6M |
| 2023 | $3.2M | -$14.7M | $0.32 | -$13M |
| 2022 | $3.1M | -$17M | $0.46 | -$15.2M |
| 2021 | $4.1M | -$9.9M | $0.35 | -$13.1M |
| 2021 | $3.9M | -$3.7M | $0.22 | -$3.9M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where ICCM ranks in Health care
Latest SEC filings
What IceCure Medical Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 5, 2026
- October 5, 2026
- September 28, 2026
- September 10, 2026
- August 24, 2026
- August 14, 2026
- August 14, 2026
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 13, 2026Form POS AM filing POS AM
- August 13, 2026Form POS AM filing POS AM
Insider trades
What the people running IceCure Medical Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 5 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 14, 2026 | Peleg MeirChief Financial Officer | Received as pay | 181,483 | - |
| August 14, 2026 | Dotan Merav NirVP, Human Resources | Received as pay | 73,890 | - |
| August 14, 2026 | Levav ShayChief Operating Officer | Received as pay | 141,483 | - |
| August 14, 2026 | Tel-Tzure Tlalit BussiVP, BD & Global Marketing | Received as pay | 101,483 | - |
| August 14, 2026 | Good ShadVP, Sales for North America | Received as pay | 131,483 | - |
Who owns ICCM
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Epoch Partner Investments Limited13G, passive | 52.2% | November 14, 2024 |
| Mr. Li Haixiang13D, may seek influence with 1 related filers | 45.8% | March 27, 2026 |
| Armistice Capital, LLC13G, passive with 1 related filers | 9.99% | August 14, 2026 |
Largest institutional holders
Insiders
5 insiders reported holding 660,503 shares in total, about $490.1K at the last price.
| Holder | Shares |
|---|---|
| Peleg MeirChief Financial Officer | 194,816 |
| Levav ShayChief Operating Officer | 146,303 |
| Good ShadVP, Sales for North America | 136,698 |
| Tel-Tzure Tlalit BussiVP, BD & Global Marketing | 106,518 |
| Dotan Merav NirVP, Human Resources | 76,168 |
Questions about ICCM
What does IceCure Medical Ltd. do?
IceCure Medical Ltd. is a company in the Health care sector, listed on NASDAQ as ICCM. Its shares trade on NASDAQ under the ticker ICCM.
What is IceCure Medical Ltd.'s net worth?
IceCure Medical Ltd. has a market value (market cap) of $2.5M at the latest share price, and shareholders' equity of $9.1M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is IceCure Medical Ltd. profitable?
No. In fiscal 2025 it reported a net loss of $15.1M on revenue of $3.4M.
How much revenue does IceCure Medical Ltd. make?
In fiscal 2025 IceCure Medical Ltd. reported revenue of $3.4M. That is 2.7% more than a year earlier.
When did IceCure Medical Ltd. last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 17, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from October 5, 2026.
Similar companies
Compare ICCM with
Follow ICCM
Get an email when IceCure Medical Ltd. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values IceCure Medical Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.